Tag: Lobe Sciences - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.

Post published:February 23, 2021
Post category:Press Release

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Post published:February 18, 2021
Post category:Press Release

Lobe Sciences Announces Management Changes and New Director

Lobe Sciences Announces Management Changes and New Director

Post published:January 18, 2021
Post category:Press Release

Lobe Sciences Announces Changes to Board of Directors

Lobe Sciences Announces Changes to Board of Directors

Post published:January 8, 2021
Post category:Press Release

Lobe Sciences Announces Further Upsizing and Second Closing of Non-Brokered Private Placement

Lobe Sciences Announces Further Upsizing and Second Closing of Non-Brokered Private Placement

Post published:January 6, 2021
Post category:Press Release

Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement

Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement

Post published:December 24, 2020
Post category:Press Release

Lobe Sciences Announces Non-Brokered Private Placement

Lobe Sciences Announces Non-Brokered Private Placement

Post published:December 14, 2020
Post category:Press Release

Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Lobe Sciences Announces Jonathan Gilbert Appointed Executive Chairman of the Board of Directors

Post published:December 14, 2020
Post category:Press Release

Lobe Sciences Commences Engineering of Nasal Mist Device

Lobe Sciences Commences Engineering of Nasal Mist Device

Post published:December 3, 2020
Post category:Press Release

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Lobe Sciences Announces CAD$23,000,000 Sale of Cowlitz Cannabis Option to Ionic Brands Corp.

Post published:December 1, 2020
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.